Crystal structure of bis(pyridine-2-carboxamide- κ ² N , O )-bis(5-sulfosalicylato- κO )copper(II), C ₂₆ H ₂₂ CuN ₄ O ₁₄ S ₂

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1The crystal structure of bis[(4-methoxyphenyl)(picolinoyl)amido-κ² <i>N:N</i>′]copper(II), C₂₆H₂₂CuN₄O₄2024
2. 2Crystal structure of poly[bis( <i>μ</i> ₂ -4,4′-(ethane-1,2-diyl)dipyridine)-( <i>μ</i> ₂ -hexafluorosilicato)-copper(II)] dimethanol solvate dihydrate], C ₂₆ H ₃₆ CuF ₆ N ₄ O ₄ SiOriginal Research · 2026
3. 3The crystal structure of bis((3-(dimethylamino)propyl)triphenylphosphonium)-(trichlorido, tribromido)chloridocopper(II)-(dichlorido, dibromido)dichloridocopper(II)-monohydrate, C 46 H 58 Br 0.95 Cl 7.05 Cu 2 N 2 OP 2Original Research · 2026
4. 4Crystal structure of poly[bis(μ ₂ -thiophene-2,5-dicarboxylato-κ ² <i>O:O′</i> )bis( <i>N,N′</i> -dimethylacetamide-k ¹ <i>O</i> )-{μ2-( <i>E</i> )-1,2-di(pyridin-4-yl)ethene-k ² <i>N:N′</i> )}dizinc(II)], C ₁₆ H ₁₆ N ₂ O ₅ SZnOriginal Research · 2026
5. 5The crystal structure of poly[( <i>μ</i> ₂ -3,5-bis(4-pyridyl)-1,2,4-triazole <i>κ</i> ² <i>N</i> : <i>N</i> ^′ )-( <i>μ</i> ₂ -3-nitrophthalato- <i>κ</i> ³ <i>O</i> , <i>O</i> ′: <i>O</i> ′′]zinc(II), C ₂₀ H ₁₂ N ₆ O ₆ ZnOriginal Research · 2026